cancer therapeutics Market Research Reports

Titlepublishedprice

Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2014

By Global Markets Direct
"......c Lymphocytic Leukemia (CLL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and p......"
22-Sep-2014$2000

Hairy Cell Leukemia – Pipeline Review, H2 2014

By Global Markets Direct
"......ages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic develop......"
22-Sep-2014$2000

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 – Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

By GBI Research
"......cation. It gives an estimation of market size for 2013 along with forecasts until 2020 for the Asia-Pacific (APAC) region, which comprises Australia, China, India and Japan. It also covers disease epidemiology, treatment algorithms, treatment pattern......"
15-Sep-2014$4995

Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2014

By Global Markets Direct
"...... Recurrent Head And Neck Cancer Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updat......"
15-Sep-2014$2000

Metastatic Ovarian Cancer – Pipeline Review, H2 2014

By Global Markets Direct
"......ysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the t......"
15-Sep-2014$2000

Anaplastic Thyroid Cancer – Pipeline Review, H2 2014

By Global Markets Direct
"......ysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the t......"
15-Sep-2014$2000

EpiCast Report: Breast Cancer (HER2-, HER2+) – Epidemiology Forecast to 2023

By GlobalData
"......s and exogenous sex hormones, gene mutations, a family history of breast cancer, overweight and obesity, physical inactivity, a sedentary lifestyle, high alcohol consumption, early age at menarche (<12 years), late age at menopause (>55 years),......"
10-Sep-2014$3995

Global Non-small Cell Lung Cancer Market 2014-2018

By Infiniti Research Limited
"......rbidity not only in developed countries but also in developing countries. One of the most common types of lung cancer is non-small cell lung cancer. It grows and spreads quite slowly. Smoking is considered as a major cause of lung cancer, although lu......"
10-Sep-2014$2500

Burkitt Lymphoma – Pipeline Review, H2 2014

By Global Markets Direct
"......plete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews ke......"
10-Sep-2014$2000

Uterine Cancer – Pipeline Review, H2 2014

By Global Markets Direct
"......th comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key player......"
10-Sep-2014$2000
Live Chat
Live Chat by Comm100